Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
GERN

Geron

$4.05

-0.2 (-4.71%)

, JNJ

Johnson & Johnson

$120.73

-1.87 (-1.53%)

12:00
06/18/18
06/18
12:00
06/18/18
12:00
Hot Stocks
Geron lower after updated Phase 2 imetelstat efficacy data »

Geron Corporation (GERN)…

GERN

Geron

$4.05

-0.2 (-4.71%)

JNJ

Johnson & Johnson

$120.73

-1.87 (-1.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTCT

PTC Therapeutics

$37.57

(0.00%)

, RHHBY

Roche

$0.00

(0.00%)

09:18
06/18/18
06/18
09:18
06/18/18
09:18
Upgrade
PTC Therapeutics, Roche rating change at William Blair »

William Blair upgrades…

PTCT

PTC Therapeutics

$37.57

(0.00%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$304.87

-0.84 (-0.27%)

, PTCT

PTC Therapeutics

$37.57

-0.75 (-1.96%)

09:13
06/18/18
06/18
09:13
06/18/18
09:13
Recommendations
Biogen, PTC Therapeutics, Roche analyst commentary at Jefferies »

PTC data add to…

BIIB

Biogen

$304.87

-0.84 (-0.27%)

PTCT

PTC Therapeutics

$37.57

-0.75 (-1.96%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$122.60

0.12 (0.10%)

08:28
06/18/18
06/18
08:28
06/18/18
08:28
Hot Stocks
Johnson & Johnson Vision announces FDA approval of iDESIGN Refractive Studio »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYGN

Myriad Genetics

$39.41

0.55 (1.42%)

, PFE

Pfizer

$36.36

0.19 (0.53%)

07:15
06/18/18
06/18
07:15
06/18/18
07:15
Hot Stocks
Myriad Genetics BRACAnalysis CDx sPMA accepted by FDA for review »

Myriad Genetics (MYGN)…

MYGN

Myriad Genetics

$39.41

0.55 (1.42%)

PFE

Pfizer

$36.36

0.19 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

KO

Coca-Cola

$44.12

0.525 (1.20%)

, GSK

GlaxoSmithKline

$41.43

-0.51 (-1.22%)

06:24
06/18/18
06/18
06:24
06/18/18
06:24
Periodicals
Coca-Cola considering bid for GlaxoSmithKline's Horlicks unit, Telegraph reports »

Coca-Cola (KO) is…

KO

Coca-Cola

$44.12

0.525 (1.20%)

GSK

GlaxoSmithKline

$41.43

-0.51 (-1.22%)

KHC

Kraft Heinz

$61.61

0.94 (1.55%)

NSRGY

Nestle

$0.00

(0.00%)

MS

Morgan Stanley

$51.17

-0.12 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

  • 21

    Jun

  • 22

    Jun

  • 25

    Jul

NVS

Novartis

$75.80

-0.19 (-0.25%)

05:34
06/18/18
06/18
05:34
06/18/18
05:34
Hot Stocks
Novartis JULIET trial demonstrates more than one-year durability of responses »

Novartis announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$75.80

-0.19 (-0.25%)

05:20
06/18/18
06/18
05:20
06/18/18
05:20
Hot Stocks
Alcon AcrySof IQ PanOptix trifocal IOL shows superior performance in trial »

Alcon, the global leader…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$36.36

0.19 (0.53%)

04:55
06/18/18
06/18
04:55
06/18/18
04:55
Conference/Events
Pfizer management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

Yesterday
BMY

Bristol-Myers

$54.81

1.165 (2.17%)

16:22
06/17/18
06/17
16:22
06/17/18
16:22
Hot Stocks
Bristol-Myers' ELOQUENT-3 trial meets primary endpoint »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 10

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.